EPA guidance on assessment of negative symptoms in schizophrenia
نویسندگان
چکیده
منابع مشابه
The Effects of Bupropion on Negative Symptoms in Schizophrenia
Abstract:Purpose:This study was designed determine the efficacy of bupropion versus placebo in subjects with negative symptoms of schizophrenia.Methods:A convenience sample of 40 patients of both genders aged 18-60 years who were living in psychiatric care centers were randomly treated with bupropion (started with 75 mg twice a day; increased to 100 mg thrice daily) or placebo. The diagnosis of...
متن کاملThe Effects of Bupropion on Negative Symptoms in Schizophrenia
Abstract:Purpose:This study was designed determine the efficacy of bupropion versus placebo in subjects with negative symptoms of schizophrenia.Methods:A convenience sample of 40 patients of both genders aged 18-60 years who were living in psychiatric care centers were randomly treated with bupropion (started with 75 mg twice a day; increased to 100 mg thrice daily) or placebo. The diagnosis of...
متن کاملRehabilitation of Schizophrenia: Adjunctive Therapy of Negative Symptoms
Negative symptoms in schizophrenia are among the important barriers against psychosocial rehabilitation of such patients. Adjunctive drugs can be used for reducing the severity of these symptoms. In this research we studied the efficacy of Clomipramine, Alprazolam, Citalopram, Bromocriptine, Fluoxetine, Nortriptyline, Maprotiline and Fluvoxamine, in this regard. After a primary prevalence surve...
متن کاملthe effects of bupropion on negative symptoms in schizophrenia
abstract:purpose:this study was designed determine the efficacy of bupropion versus placebo in subjects with negative symptoms of schizophrenia.methods:a convenience sample of 40 patients of both genders aged 18-60 years who were living in psychiatric care centers were randomly treated with bupropion (started with 75 mg twice a day; increased to 100 mg thrice daily) or placebo. the diagnosis of...
متن کاملNegative symptoms in schizophrenia
The negative symptoms have been described in association with schizophrenia since the early days of it being recognized as an entity. However, their elusive nature kept them unacknowledged until there was a revival of interest in them following the development of specific quantifying measures. Over the past three decades, there has been a tremendous surge in research on their types, measurement...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Psychiatry
سال: 2021
ISSN: 0924-9338,1778-3585
DOI: 10.1192/j.eurpsy.2021.11